Late toxicity and quality of life with prostate only or whole pelvic radiation therapy in high risk prostate cancer (POP-RT): A randomised trial
Vedang Murthy(Homi Bhabha National Institute), Umesh Mahantshetty(Homi Bhabha National Institute), Rahul Krishnatry, Gagan Prakash(Homi Bhabha National Institute), Priyamvada Maitre(Homi Bhabha National Institute), Jatin Bhatia(Homi Bhabha National Institute), Ganesh Bakshi(P. D. Hinduja Hospital and Medical Research Centre), Santosh Menon(Homi Bhabha National Institute), Mahendra Pal(Homi Bhabha National Institute), Sadhana Kannan(Homi Bhabha National Institute)
Cited by 70
Related Papers
The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies
|Clinical and Translational Radiation Oncology|2018|932
Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study
|Radiotherapy and Oncology|2016|695
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694